# DoW Peer Reviewed Medical, Clinical Trial Award

Source: https://welltoldgrants.com/grants/ht942526prmrpcta-dow-peer-reviewed-medical-clinical-trial-award/  
Official notice: https://www.grants.gov/search-results-detail/362321

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 9 awards worth $94.5 million in total. Applications closed on September 22, 2026.

| Field | Value |
|---|---|
| Opportunity number | HT942526PRMRPCTA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | September 22, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 9 |
| Total funding | $94.5 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have significant impact on the treatment and management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP topic areas and FY26 PRMRP strategic goals. Distinctive Features: Must support a clinical trial. Supports two different application categories, based on the phase of planning for the clinical trial: Clinical Trial Only or Clinical Trial with Planning Phase. The Clinical Trial with Planning Phase option is intended to support the final phase of regulatory activities and planning activities that are necessary to be completed prior to initiation of the clinical trial. The planning phase cannot be used to finalize the intervention or support animal studies. Applications that already have regulatory approvals in place and are submitting to the Clinical Trial Only option may be prioritized over those requesting the Planning Phase option. Animal studies are not supported. Studies must complete all preclinical empirical laboratory work prior to the award start date. Supports three funding levels, each offered with and without a Planning Phase: Funding Level 1: Supports phase 0 or phase 1 clinical trials or non-phased trials with fewer than 100 participants. Funding Level 2: Supports phase 2 clinical trials or non-phased trials with fewer than 300 participants. Funding Level 3: Supports phase 3 clinical trials or non-phased trials with more than 300 participants. Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $94.5M to fund approximately 9 Clinical Trial Award applications with total cost caps of $800,000 for the planning phase of a Clinical Trial with Planning Phase, $6M for Funding Level 1, $10M for Funding Level 2, and $20M for Funding Level 3 per award. The maximum period of performance is 4 years for the clinical trial, and 12 months for the planning phase. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.

## Questions people ask

### Is HT942526PRMRPCTA still open?

No. It closed on September 22, 2026. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoW Peer Reviewed Medical, Clinical Trial Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoW Peer Reviewed Medical, Clinical Trial Award?

Closed September 22, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $94.5 million in total across about 9 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.